Pain Therapeutics (PTIE) Reports FDA Clearance of Investigational New Drug (IND) Application for PTI-125
Tweet Send to a Friend
Pain Therapeutics, Inc. (NASDAQ: PTIE) is pleased to announce that the U.S. Food and Drug Administration (FDA) has cleared its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE